MeSH term
Frequency | Condition_Probility | Adult | 3 | 0.0 |
Animals | 47 | 0.0 |
Chickens | 2 | 0.0 |
Humans | 46 | 0.0 |
RNA, Messenger/metabolism | 7 | 0.0 |
Research Support, Non-U.S. Gov't | 56 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 30 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Comparative Study | 13 | 0.0 |
Crosses, Genetic | 3 | 0.0 |
Immunohistochemistry | 9 | 0.0 |
Mice | 26 | 0.0 |
Mice, Knockout | 9 | 0.0 |
Amino Acid Sequence | 22 | 0.0 |
Animals, Genetically Modified | 2 | 0.0 |
Female | 6 | 0.0 |
Male | 7 | 0.0 |
Nerve Tissue Proteins/genetics/*metabolism | 8 | 5.0 |
Precipitin Tests | 4 | 0.0 |
Protein Binding | 10 | 0.0 |
Alzheimer Disease/metabolism | 7 | 10.0 |
Caenorhabditis elegans | 2 | 2.0 |
Cells, Cultured | 13 | 0.0 |
Drosophila | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Sequence Homology, Amino Acid | 16 | 0.0 |
Species Specificity | 3 | 0.0 |
Nerve Tissue Proteins/metabolism | 4 | 1.0 |
Tretinoin/*pharmacology | 2 | 0.0 |
Amyloid beta-Protein Precursor/*metabolism | 8 | 11.0 |
Nerve Tissue Proteins/*metabolism | 7 | 2.0 |
Phosphorylation | 5 | 0.0 |
Nerve Tissue Proteins/genetics | 3 | 1.0 |
Rats | 17 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Blotting, Western | 3 | 0.0 |
Brain/cytology/metabolism | 2 | 5.0 |
Heterozygote | 2 | 0.0 |
Homozygote | 2 | 0.0 |
Neurons/cytology/drug effects/metabolism | 2 | 10.0 |
Amyloid beta-Protein Precursor/*genetics | 8 | 12.0 |
Nerve Tissue Proteins/*genetics | 4 | 0.0 |
Amyloid beta-Protein Precursor/immunology/*metabolism | 3 | 75.0 |
Cell Line | 10 | 0.0 |
Molecular Sequence Data | 27 | 0.0 |
Nerve Tissue Proteins/immunology/*metabolism | 2 | 14.0 |
Aged | 4 | 0.0 |
Alzheimer Disease/*genetics/*metabolism | 2 | 12.0 |
Brain Chemistry/*genetics | 2 | 4.0 |
Nerve Tissue Proteins/genetics/metabolism | 3 | 4.0 |
Cerebral Cortex/*metabolism | 2 | 3.0 |
Copper/*metabolism | 3 | 3.0 |
Mice, Inbred C57BL | 6 | 0.0 |
Alzheimer Disease/*metabolism | 7 | 3.0 |
CHO Cells | 3 | 0.0 |
Chondroitin Sulfates/metabolism | 3 | 10.0 |
Hamsters | 3 | 0.0 |
Binding Sites | 5 | 0.0 |
Brain/*metabolism | 4 | 0.0 |
COS Cells | 4 | 0.0 |
Cytoplasm/metabolism | 6 | 0.0 |
Gene Expression | 4 | 0.0 |
Peptide Fragments/chemistry | 2 | 1.0 |
Sequence Alignment | 5 | 0.0 |
Transfection | 10 | 0.0 |
Base Sequence | 12 | 0.0 |
In Vitro | 2 | 0.0 |
Amyloid beta-Protein Precursor/genetics/*metabolism | 8 | 28.0 |
DNA Primers | 2 | 0.0 |
Cell Survival/physiology | 2 | 1.0 |
Peptide Fragments/pharmacology | 2 | 0.0 |
Amyloid beta-Protein Precursor/*biosynthesis | 2 | 33.0 |
Alternative Splicing | 6 | 0.0 |
Nerve Tissue Proteins/*physiology | 2 | 3.0 |
Nuclear Proteins/*physiology | 2 | 1.0 |
Rats, Sprague-Dawley | 3 | 0.0 |
Tissue Distribution | 3 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Recombinant Proteins/genetics/metabolism | 2 | 0.0 |
Amyloid beta-Protein Precursor/genetics/*physiology | 2 | 66.0 |
In Situ Hybridization | 3 | 0.0 |
Nerve Tissue Proteins/genetics/*physiology | 2 | 6.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Protein Processing, Post-Translational | 3 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Middle Aged | 3 | 0.0 |
Hela Cells | 2 | 0.0 |
Protein Structure, Tertiary | 6 | 0.0 |
Transcription, Genetic | 6 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Isomerism | 2 | 0.0 |
RNA, Messenger/*metabolism | 2 | 0.0 |
Conserved Sequence | 3 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Multigene Family | 2 | 0.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
*Alternative Splicing | 2 | 0.0 |
Molecular Probes/genetics | 2 | 2.0 |
Neurons/metabolism | 4 | 1.0 |
Alzheimer Disease/genetics | 2 | 4.0 |
Gene Expression Regulation | 2 | 0.0 |
Brain Chemistry | 2 | 0.0 |
Heparin/*metabolism | 2 | 2.0 |
Zinc/*metabolism | 2 | 3.0 |
Cell Differentiation | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Organ Specificity | 2 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
Genetic Vectors | 2 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Signal Transduction | 4 | 0.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
*Adaptor Proteins, Signal Transducing | 3 | 0.0 |
Glutathione Transferase/metabolism | 2 | 0.0 |